Hutch News

Hutch News

Stories tagged 'Prostate Cancer'

Parsing the deadliness of prostate cancer

Fred Hutch researcher zeroes in on biomarkers to better predict aggressive form of the disease

Sept. 4, 2018 | By Diane Mapes / Fred Hutch News Service

Prostate cancers are not all the same. Some are extremely aggressive: They can and do kill. Others are slow-growing and don’t kill: Men die with them, not of them. How can doctors and patients discern which one is which? Fred Hutch's Dr. Janet Stanford believes she may have found a way.

View story >


Dr. James Dai receives $2.1M NCI grant for cancer biomarker research

Biostatistician plans to use funds to develop statistical models to further precision cancer prevention and treatment

Aug. 20, 2018 | By Colin Petersdorf / Fred Hutch News Service

Fred Hutch biostatistician Dr. James Dai recently was awarded a $2.1 million grant from the National Cancer Institute to develop new analytical methods for identifying genetic and epigenetic alterations that drive cancers. He hopes this work will facilitate the discovery of molecular cancer drivers — biomarkers — and the development of new preventive, diagnostic and prognostic techniques.

View story >


Supper, sleep, circadian rhythms and cancer risk

Q&A: How going against our internal clock can trigger disease

July 19, 2018 | By Diane Mapes / Fred Hutch News Service

A new study out of Barcelona suggests when you eat may be just as critical as what you eat, at least with regard to breast and prostate cancer risk. We sat down with principal investigator Dr. Manolis Kogevinas, currently a visiting professor at Fred Hutch, for his insights on how circadian disruption can impact our health.

View story >


What's new in prostate cancer: 5 takeaways

‘Many reasons for optimism’ says expert at annual community symposium

May 1, 2018 | by Susan Keown / Fred Hutch News Service

What's new in prostate cancer in 2018? The latest in prostate cancer treatment, screening, survivorship and more.

View story >


How do we bridge gaps in health equity?

Researchers and community members discuss outreach, relationship building at 2018 Pathways to Equity Symposium

April 30, 2018 | By Diane Mapes / Fred Hutch News Service

View story >


Finasteride can reduce prostate cancer risk long term

Fred Hutch study taps big data to tease out extended cancer-prevention benefit of drug used for enlarged prostate, hair loss

March 21, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch public health researcher Dr. Joe Unger used an innovative trial design to confirm finasteride, a drug used to treat enlarged prostate or hair loss in men, has a long-term protective effect against prostate cancer.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Magazine Archive
Back issues of Hutch Magazine

Financial Reporting
Fiscal highlights & Annual Reports

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.